Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score

Ítems similars

• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching
  per: Onozawa, Mizuki, et al.
  Publicat: (2018)
• Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy
  per: Cooperberg, Matthew R., et al.
  Publicat: (2009)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  per: Satoru Ueno, et al.
  Publicat: (2018-03-01)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  per: Ueno, Satoru, et al.
  Publicat: (2018)
• Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy
  per: Lim, Jasmine, et al.
  Publicat: (2020)